Drug Discovery
  • Target deconvolution
  • Target validation
  • Mode of action analysis
  • Toxicity profiling
Clinical Proteomics
  • Translational research
  • Companion diagnostics
  • Complex biomarker signatures
  • Drug response prediction
Disease and Systems Biology
  • Signal transduction
  • Disease mechanisms
  • Mechanistic biomarkers
  • Multi-omics integration
Accelerating drug and biomarker discovery

OmicScouts is a chemical proteomics company focused on supporting drug and biomarker discovery with its unique expertise and innovative technologies.

Founded by leading proteomics researchers, the company has a track record in delivering significant collaborations with top pharmaceutical and biotechnology companies.

We provide and develop proteome-wide assays that work with native proteins in a physiological setting and enable the identification of small molecule drug targets, target engagement markers, molecular mechanisms of action and drug response biomarkers.

OmicScouts supports your drug and biomarker discovery projects with end-to-end solutions tailored to project specific needs.

Latest News
Feb. 18 - Juni 19, 2019
Together with the TU Munich, the Science for Life Laboratory at the KTH Royal Institute of Technology in Stockholm and at the Upps...
Mai 29 - Juli 2, 2019
We congratulate our co-founders and scientific advisors Bernhard Kuster and Mathias Wilhelm and their colleagues and collaborators...
Juni 17 - Juni 20, 2019
Join us at the the World Pharma Week in Boston. We will speak in the Chemical Biology and Target Validation track on June 18, 2019...

Scientific excellence in proteomics, computational biology and drug discovery

Read More »

Collaborations with leading academic and industry partners

Read More »

Further informations on job openings

Read More »